Basis: (FMP quote price / unrounded diluted TTM EPS) / explicitly dated EPS growth percent. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-09-15T00:00:44.500Z.
Calculation as of: 2026-09-15T00:00:44.500Z.
Quote observation: 2026-09-14T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: e5d1d00653286325cbef7234d4b00ccf93b8387f933ef7048708e998447bf1a5
PEG RATIO
N/A
Moderna, Inc.
Market Cap
$58.20B
PEG Ratio
N/A
| NAME | MARKET CAP | PEG RATIO |
|---|---|---|
| Moderna, Inc. (MRNA) | $58.20B | N/A |
| Cardinal Health, Inc. (CAH)vs › | $55.01B | N/A |
| Cencora, Inc. (COR)vs › | $63.47B | N/A |
| Becton, Dickinson and Company (BDX)vs › | $50.40B | N/A |
| Boston Scientific Corporation (BSX)vs › | $66.96B | N/A |
| Edwards Lifesciences Corporation (EW)vs › | $49.24B | N/A |
| Humana Inc. (HUM)vs › | $48.93B | N/A |
| Teva Pharmaceutical Industries Limited (TEVA)vs › | $45.09B | N/A |
| IQVIA Holdings Inc. (IQV)vs › | $43.73B | N/A |
| Agilent Technologies, Inc. (A)vs › | $41.46B | N/A |
PEG Ratio
N/A
P/E Ratio
N/A
PEG Ratio = PE Ratio / Earnings Growth Rate
The PEG ratio adjusts the PE ratio for expected earnings growth. A PEG near 1 is often considered fairly valued relative to growth.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
